In the first installment of a new series, Peter Doshi, Assistant Professor at the University of Maryland School of Pharmacy and Associate Editor at The BMJ, asks why authorities are approving drugs with little evidence they do anything to tackle the problem of antimicrobial…
Source:Questions over value of new antibiotics to tackle resistance
Thursday, March 26, 2015
Questions over value of new antibiotics to tackle resistance
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment